These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12907210)

  • 1. Study on chemosensitivity of oral squamous cell carcinomas by histoculture drug response assay.
    Ariyoshi Y; Shimahara M; Tanigawa N
    Oral Oncol; 2003 Oct; 39(7):701-7. PubMed ID: 12907210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Correlation of the Histoculture Drug Response Assay for Head and Neck Cancer.
    Hoffman RM
    Methods Mol Biol; 2018; 1760():83-92. PubMed ID: 29572796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of survival in patients with head and neck cancer using the histoculture drug response assay.
    Singh B; Li R; Xu L; Poluri A; Patel S; Shaha AR; Pfister D; Sherman E; Goberdhan A; Hoffman RM; Shah J
    Head Neck; 2002 May; 24(5):437-42. PubMed ID: 12001073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemosensitivity testing of oral and maxillofacial cancer with biopsy specimens].
    Chen W; Zhou X; Xu Q; Guo W; Lin L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Nov; 37(6):404-7. PubMed ID: 12641948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
    Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
    Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y
    Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Usefulness of the Histoculture Drug Response Assay for Breast Cancer.
    Hoffman RM; Tanino H
    Methods Mol Biol; 2018; 1760():93-100. PubMed ID: 29572797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro chemosensitivity profile of oral squamous cell cancer and its correlation with clinical response to chemotherapy.
    Pathak KA; Juvekar AS; Radhakrishnan DK; Deshpande MS; Pai VR; Chaturvedi P; Pai PS; Chaukar DA; D'Cruz AK; Parikh PM
    Indian J Cancer; 2007; 44(4):142-6. PubMed ID: 18322356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting nedaplatin sensitivity of cervical cancer using the histoculture drug response assay.
    Kato R; Hasegawa K; Achiwa Y; Okamoto H; Torii Y; Oe S; Udagawa Y
    Eur J Gynaecol Oncol; 2011; 32(4):381-6. PubMed ID: 21941957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer.
    Hoffman RM
    Methods Mol Biol; 2018; 1760():61-72. PubMed ID: 29572794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High clinical predictability of histoculture drug response assay (HDRA) for drug-sensitivity of cancer of the digestive organs].
    Kubota T; Furukawa T; Kitajima M
    Gan To Kagaku Ryoho; 1993 Mar; 20(4):461-6. PubMed ID: 8452384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical applications of the histoculture drug response assay.
    Furukawa T; Kubota T; Hoffman RM
    Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histoculture drug response assay on non-small cell lung cancer].
    Yoshimasu T; Oura S; Maebeya S; Tanino H; Bessho T; Arimoto J; Sakurai T; Matsuyama K; Naito Y; Furukawa T; Yano T; Suzuma T; Hirai I
    Gan To Kagaku Ryoho; 2000 May; 27(5):717-22. PubMed ID: 10832440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric DNA analysis and chemosensitivity in squamous cell carcinoma of the head and neck].
    Miyagi M; Soda T; Nakashima T
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Dec; 97(12):2247-58. PubMed ID: 7861297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitivity testing of human mouth carcinoma cell line.
    Tachikawa T; Kumazawa H; Hori Y; Sai S; Kita J; Yamashita T; Kumazawa T; Maehara Y; Kohnoe S
    Acta Otolaryngol Suppl; 1993; 500():154-7. PubMed ID: 8452015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
    Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Significance of 5-Fluorouracil Chemosensitivity Testing in Patients with Colorectal Cancer.
    Ji WB; Um JW; Ryu JS; Hong KD; Kim JS; Min BW; Joung SY; Lee JH; Kim YS
    Anticancer Res; 2017 May; 37(5):2679-2682. PubMed ID: 28476844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Clinical Correlation of the Histoculture Drug Response Assay for Ovarian Cancer.
    Hoffman RM; Jung PS; Kim MB; Nam JH
    Methods Mol Biol; 2018; 1760():73-81. PubMed ID: 29572795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction chemotherapy based on histoculture drug response assay for a patient with advanced thymic cancer--a case report].
    Tanino H; Miyoshi S; Furukawa T; Bessho T; Maebeya S; Suzuma T; Hirai I; Arimoto J; Harada N; Hoso T; Naito Y
    Gan To Kagaku Ryoho; 1997 May; 24(7):861-4. PubMed ID: 9170526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.